Article Insights

Keep tabs on current events and expert interest. These are the output of Science4Data’s Article Insight: Powerful analysis on the headlines shaping our world.

GSK announces new data presentations from the DREAMM programme exploring investigational belantamab mafodotin in patients with relapsed/refractory multiple myeloma

By |2020-06-05T08:24:30-05:00June 5th, 2020|Categories: Article Analysis|